Financial GeoVax Anticipates Significant 2025 Progress With Catalyst-Rich Milestones Across Key Programs 05.02.2025 / 15:06 CET/CEST The issuer is solely responsible for the content of this ...

By treating DNA as a language, Brian Hie’s “ChatGPT for genomes” could pick up patterns that humans can’t see, accelerating ...

Arvinas, Inc. (NASDAQ:ARVN – Get Free Report)’s share price reached a new 52-week low on Monday after Barclays lowered their price target on the stock from $48.00 to $32.00. Barclays currently has an ...

Instead of encouraging people to buy things they don’t need, how can we creatively and intuitively deliver what they do need? Adapted from Nonlinear: Navigating Design With Curiosity and Conviction ...

We recently published a list of 10 Best Wide Moat Stocks to Invest In. In this article, we are going to take a look at where ...

Pacer Advisors Inc. decreased its position in argenx SE (NASDAQ:ARGX – Free Report) by 5.2% during the fourth quarter, Holdings Channel reports. The fund owned 789 shares of the company’s stock after ...

AI-powered simulation software could help biomanufacturers understand the economics and sustainability of protein production at large scale.

Bio-Techne beat second-quarter profit and revenue estimates on Wednesday, helped by growth in its protein sciences unit that makes products to develop therapies ...

Zenas BioPharma (ZBIO) announced its 2024 accomplishments, outlined its key business objectives for 2025 and announced preliminary unaudited ...

A research team has developed a biodegradable polymer-based delivery system that efficiently transports mRNA.

CEO Jerome Grant highlighted a strong quarter with revenue growing over 15% year-over-year to $201.4 million, driven by growth across both divisions and a 22% increase in new student starts. Average ...

Q4 2024. Management View. CEO Guido Oelkers highlighted an 8% growth in Q4 revenues, driven primarily by hematology ...